Literature DB >> 4157810

Polycythaemia vera.

K E Halnan, M H Russell.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 4157810     DOI： 10.1016/s0140-6736(65)90812-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  8 in total

1.  [Nosological significance of preleukemia].

Authors:  H Brücher
Journal:  Blut       Date:  1973-04

2.  Polycythemia: diagnosis, pathophysiology and therapy. I.

Authors:  J H Jepson
Journal:  Can Med Assoc J       Date:  1969-02-08       Impact factor: 8.262

3.  Survival of polycythaemia vera patients treated with radioactive phosphorus.

Authors:  J B Harman; E M Ledlie
Journal:  Br Med J       Date:  1967-04-15

4.  Treatment of polycythaemia vera.

Authors:  P J Watkins; G H Fairley; R B Scott
Journal:  Br Med J       Date:  1967-06-10

5.  Treatment of polycythaemia by 32-P.

Authors:  E M Ledlie
Journal:  Proc R Soc Med       Date:  1966-11

6.  Treatment and prognosis of polycythaemia managed by non-radioactive methods.

Authors:  M C Israëls
Journal:  Proc R Soc Med       Date:  1966-11

7.  Use and risks of phosphorus-32 in the treatment of polycythaemia vera.

Authors:  Claude Parmentier
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-09-03       Impact factor: 9.236

8.  Treatment of polycythaemia vera by radiophosphorus or busulphan: a randomized trial. "Leukemia and Hematosarcoma" Cooperative Group, European Organization for Research on Treatment of Cancer (E.O.R.T.C.).

Authors: 
Journal:  Br J Cancer       Date:  1981-07       Impact factor: 7.640
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.